[1]
Heleniak, Z. et al. 2017. The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis. Current Issues in Pharmacy and Medical Sciences. 29, 4 (Jan. 2017), 180–183. DOI:https://doi.org/10.1515/cipms-2016-0038.